Introduction {#S1}
============

Iron oxide nanoparticles have established themselves as a useful tool for biomedical applications ranging from subcellular manipulation to whole body imaging, and treatment of anaemia and cancer \[[@R1]--[@R12]\]. The importance of cell or tissue iron quantification to assess both efficacy and toxicity is readily apparent; however, the most reliable assays, for example inductively coupled plasma-mass spectrometry (ICP-MS), require specialised and costly equipment \[[@R13]--[@R15]\]. Existing less costly and simple chemical assay methods have not been optimised or validated to quantify low levels of iron (\<1 μg) that are typically recovered from tissue or cell culture systems mixed with iron oxide nanoparticles \[[@R16]\]. Studies of cancer targeting \[[@R17]--[@R22]\], magnetic hyperthermia \[[@R17],[@R18],[@R23],[@R24]\], imaging \[[@R8],[@R25]\], toxicology \[[@R26]\], cell separation \[[@R27]\] and stem cell tracking \[[@R28],[@R29]\] would benefit significantly with development of a more accessible method to quantify iron from biological matrices that provides accuracy and precision comparable to ICP-MS, the current gold standard. Such an assay would enhance research progress and toxicity assessments, by enabling quantitative comparisons of cell-nanoparticle association that can be related to specific nanoparticle constructs or properties.

ICP-MS is often considered as the gold standard to measure iron primarily because of high sensitivity -- detection limits to parts per trillion (nanogram per litre) are possible. This is a lower detection threshold than achievable with other spectroscopic techniques such as ICP-atomic emission spectroscopy (ICP-AES), graphite furnace-atomic absorption spectroscopy (GF-AAS) or flame atomic absorption spectroscopy (AAS) \[[@R13],[@R15]\]. In addition to its high sensitivity, ICP-MS provides flexibility to detect multiple elements for simultaneous interrogation. To be fair, the detection limits possible with ICP-MS for iron quantification require specialised instrument configurations having octopole reaction cell/mass filter(s) to discriminate Fe from among the many possible polyatomic interferences; and, pristine sample preparation to avoid contamination with ubiquitous environmental Fe \[[@R30]\]. Thus, ICP-MS and other sensitive mass spectrometry technologies, although superior in many ways, demand significant financial investment to acquire and maintain the instrumentation, and to develop and maintain dedicated facility infrastructure.

Colorimetric methods based upon absorption of light by a sample, that is ultraviolet/visible (UV/Vis) spectrophotometry, to quantify intracellular iron have long existed \[[@R31]--[@R33]\]. Refinement continues to improve their sensitivity and accuracy \[[@R34]--[@R36]\]. When bound to free iron ions, chelators such as the triazines absorb very strongly in the UV/Vis range, with molar absorptivity of \~10^4^ M^−1^ cm^−1^. Many chromogenic substrates such as bathophenanthroline sulfonate, ferrozine or ferene have been utilised for iron quantification in human serum or environmental samples \[[@R31]--[@R33]\]. The colorimetric assay developed by Riemer *et al*. \[[@R34]\] incorporates potassium permanganate-mediated digestion/oxidation and iron detection by ferrozine and is one of the most commonly employed methods for detecting cellular iron.

We report on the development of an optimised triazine-based colorimetric assay with ferene-s, a more sensitive chromogenic compound for iron detection. We introduce a simplified digestion procedure to ensure accuracy among varying experimental configurations, and validation of results with ICP-MS using reference standard materials. The assay presented is a simple, sensitive, robust and highly adaptable method of iron quantitation for a wide variety of cellular applications of iron oxide nanoparticles. It is capable to provide accurate iron ion concentration measurements to \~2 × 10^−6^ M (1 × 10^−7^ g/ml sample).

Materials and methods {#S2}
=====================

Iron standards and nanoparticles {#S3}
--------------------------------

All iron standards were prepared from a stock certified standard reference material (FeCl~3,~ Iron Standard for ICP, 1000 ± 2 mg/l Fe in 2% nitric acid, Sigma-Aldrich, St. Louis, MO). Iron oxide nanoparticle formulations used in this study generally comprised iron oxide with a polysaccharide (dextran or starch) polymer as either coating material (core--shell nanoparticles) or as matrix (iron oxide crystallites in polymer matrix). Specifically, particles used were: 80 and 100 nm plain BNF-Starch and 100 nm plain BNF-Dextran particles (Bionized NanoFerrite, Micromod Partikeltechnologie GmbH, Rostock, Germany), 20 nm plain nanomag^®^-D-spio particles and 500 nm nanomag^®^-D-plain (dextran iron oxide composite particles, Micromod Partikeltechnologie GmbH, Rostock, Germany) and conjugated or unconjugated magnetic microbeads (Anti ErbB2 or Basic MicroBeads, Miltenyi Biotec Inc., Auburn, CA). BNF particles are core--shell particles with an iron oxide core (\~45 nm) comprising multiple iron oxide crystallites having parallelepiped shapes with long dimension of 15--20 nm \[[@R20],[@R23],[@R37],[@R38]\] and a shell of starch or dextran. In contrast 20 nm nanomag^®^-D-spio particles comprise iron oxide crystals with diameters of 7--10 nm embedded in dextran matrix \[[@R38],[@R39]\]. The nanoparticles were used as provided by manufacturers.

Nanoparticle loading into cells {#S4}
-------------------------------

Human prostate carcinoma DU145 cells (ATCC, Manassas, VA) were maintained and propagated according to the ATCC protocol. Cells were cultured at 37°C and 5% CO~2~ in T-75 tissue culture flasks containing RPMI 1640 medium and 10% foetal bovine serum (Life Technologies, Carlsbad, CA). Exponentially growing cells were treated by adding iron oxide nanoparticles (50--150 μg/ml Fe) and sterile poly-L-lysine (PLL, 0.5--2.0 μg/ml; Sigma-Aldrich, St. Louis, MO) to the culture media. After 24 h, the flask was rinsed three times with Dulbecco's phosphate buffered saline (PBS) to remove extracellular nanoparticles. Cells were detached by brief exposure to 0.25% trypsin-EDTA followed by resuspension in culture media. After centrifugation and two more washes with PBS the fully suspended cells were counted. Aliquots with equal number of cells were transferred to 1.5 ml microfuge tubes and frozen to −80°C as cell pellets. To obtain cells with low, medium and high iron content, the concentration of 80 nm BNF-Starch particles was kept constant at 150 μg/ml while varying the concentrations of PLL (1, 1.5 and 2 μg/ml respectively).

Ferene-s assay {#S5}
--------------

Ferrozine (3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine-4′,4″-disulfonic acid sodium salt) and ferene-s (3-(2-pyridyl)-5,6-di(2-furyl)-1,2,4-triazine-5′,5″-disulfonic acid disodium salt) were purchased (Sigma-Aldrich, St. Louis, MO). A detailed protocol with lists of materials and equipment for this assay is included in the [Supplementary Materials and Methods](#SD1){ref-type="supplementary-material"}. Briefly, the sample to be measured was directly added to a 1× working solution (5 mM ferene-s, 0.2 M L-ascorbic acid in 0.4 M ammonium acetate buffer, pH \~4.3) in a total volume of 1 ml. The mixture was incubated at room temperature in the dark for ≥20 h. The absorbance was measured at 595 nm in a flat bottom standard 96-well plate (300 μl per well in triplicates) using SpectraMax-M5 plate reader (Molecular Devices Corporation, Sunnyvale, CA). FeCl~3~ iron standards were always included (0--4 μg/ml). Alternatively, the samples were digested first with concentrated nitric acid (100 μl) for 2 h at 70°C. The digested samples were allowed to cool to room temperature before neutralisation with 10 N NaOH (160 μl). The 1× working solution (900 μl) was added to the neutralised sample (100 μl). After 30 min at room temperature the absorbance was measured at 595 nm in a flat bottom standard 96-well plate (300 μl per well in triplicates).

For comparison to the ferrozine assay, the 1× working solution was prepared with 5 mM ferrozine instead of ferene-s and the absorbance was measured at 560 nm.

Kinetics of iron oxide nanoparticles in working solution of the ferene-s assay {#S6}
------------------------------------------------------------------------------

Samples were added directly to 1× working solution (total volume of 1 ml). The absorbance was measured at 595 nm in a flat bottom standard 96-well plate (300 μl per well in triplicates) at 30 min intervals for up to 24 h. Absorbance readings for DU145 cells containing medium and high BNF-Starch concentrations were adjusted to reflect equivalent number of cells to that of cells with low Fe content.

Inductively coupled plasma-mass spectrometry (ICP-MS) {#S7}
-----------------------------------------------------

Frozen cell-nanoparticle samples were thawed at room temperature, and then prepared for ICP-MS using methods previously described \[[@R25],[@R40]\]. Briefly, thawed samples were thermally digested in 50% nitric acid using a two stage ramp-to-temperature microwave method (MARS5 Xpress microwave, CEM Corporation, Matthews, NC). Digested samples were diluted for mass spectrometric evaluation and the total iron content of the samples was determined using an Agilent 7500ce ICP-MS (Agilent Technologies, Santa Clara, CA). An eight-point calibration curve was performed prior to sample analysis. At least three samples were analysed by ICP-MS for each cell preparation. The total iron content per cell was calculated, accounting for the number of cells provided as well as dilution factors, as the mean value for these samples.

Ferrozine assay (Riemer) {#S8}
------------------------

The assay was performed essentially as reported by Riemer *et al*. \[[@R34]\]. Briefly, cell pellets were lysed with 300 μl of 50 mM NaOH for 2 h at room temperature with constant mixing using a rotary shaker. An equivalent volume (300 μl) of 10 mM HCl was then added followed by the addition of 300 μl of freshly prepared solution containing 2.25% KMnO~4~ and 0.7 M HCl. The samples were then transferred to a heat block and heated at 60 °C for 2 h. The heated samples were allowed to cool to room temperature before addition of 90 μl of freshly prepared iron detection solution (6.5 mM ferrozine in 1 M L-ascorbic acid and 2.5 M ammonium acetate). After 30 min, 280 μl aliquots of the samples were transferred to a well of a 96-well plate in triplicates and the absorbance at 550 nm was recorded. Iron oxide nanoparticles and FeCl~3,~ iron standards (0--4 μg) were prepared similarly.

Modified protocol to correct for path length for 96-well plate readers {#S9}
----------------------------------------------------------------------

A fixed volume of 300 μl is used for each well, triplicate per sample, and a standard curve is included in each experiment. Readings of 96-well plates are dependent on both the concentration and the volume of the sample, thus each absorbance reading is converted to the total absorbance for the entire sample (by multiplying with the ratio of the total volume/volume of sample in the well). The total absorbance therefore depends only on the total amount of iron in the sample and not on the concentration. As shown in [Supplementary Table S4](#SD1){ref-type="supplementary-material"} and [Figure 1(C)](#F1){ref-type="fig"} the average slope of total net absorbance for Fe standards is about 1.7 absorbance units per μg of iron with 4.4% coefficient of variation. The total amount of iron in an unknown sample could therefore be determined by dividing the total absorbance units of the unknown by this slope.

Results {#S10}
=======

Comparison of ferene-s to ferrozine using Fe standards {#S11}
------------------------------------------------------

We compared the most commonly used chromogenic iron-chelator ferrozine to ferene-s. Ferene-s is structurally similar to ferrozine ([Figure 1](#F1){ref-type="fig"}) and it has been reported to have a higher molar absorptivity \[[@R32],[@R41]\]. [Figure 1](#F1){ref-type="fig"} shows UV/Vis spectra of ferrozine (A) and ferene-s (B) for FeCl~3~ standards ranging from 0 to 2 μg in a final volume of 1 ml. [Figure 1(C)](#F1){ref-type="fig"} shows the standard curves for both compounds measured at the peak absorbance for each compound (560 nm for ferrozine and 595 nm for ferene-s). The assay developed uses a 96-well plate format to measure optical density based on volumes of 300 μl per well. To obtain accurate estimates of the molar absorptivity of the two compounds we measured the absorbance using a standard 1 ml cuvette (see [Supplementary Table S1](#SD1){ref-type="supplementary-material"}). The calculated mean molar absorptivity ± SD obtained was 27 626 ± 523 M^−1^ cm^−1^ for ferrozine and 35 194 ± 831 M^−1^ cm^−1^ for ferene-s. These values are similar to the reported reference values \[[@R41]--[@R44]\]. The molar absorptivity of ferene-s is about 28% higher than that of ferrozine. Therefore, ferene-s was chosen as the iron chelator for the assay development.

Comparison of ferene-s assay to ICP-MS {#S12}
--------------------------------------

To validate results obtained from the ferene-s assay, we compared with results obtained from ICP-MS for several commercially available iron oxide nanoparticles. The measured iron contents of the four different formulations of nanoparticles are shown in [Table 1](#T1){ref-type="table"}. The values obtained by ferene-s assay are similar to those obtained by ICP-MS. We also compared the intracellular iron concentration for one of these nanoparticles (BNF-Starch) that were determined with both methods. The mean ± SD of iron in BNF-Starch loaded DU145 cells was (44.3 ± 5.0) × 10^−12^ g/cell with ferene-s assay and (45.5 ± 14.6) × 10^−12^ g/cell for ICP-MS ([Table 1](#T1){ref-type="table"}).

Kinetics of iron oxide nanoparticles in working solution of the ferene-s assay {#S13}
------------------------------------------------------------------------------

The formation of iron ferene-s complex (Fe^2+^: ferene-s) in the working solution is rapid for FeCl~3~ standards (\<30 min at room temperature, [Supplementary Figure S1](#SD1){ref-type="supplementary-material"}). Once formed, the complex is stable (at least 1 week, [Supplementary Table S6](#SD1){ref-type="supplementary-material"}). We note, however, that with other sample matrices the formation of iron ferene-s complex can be slow depending on the formulation of nanoparticles or their intracellular location. The kinetics of complex formation obtained for several different nanoparticles is shown in [Figure 2(A)](#F2){ref-type="fig"}. The saturation time for the absorbance readings differed among the formulations; however, by about 8 h they had all achieved a constant value. The kinetics of complex formation for intracellular BNF-Starch was still slower as shown in [Figure 2(B)](#F2){ref-type="fig"} reaching a constant value at \~20 h.

Digestion with acid {#S14}
-------------------

Intracellular iron can be released more rapidly by digestion with concentrated nitric acid. [Figure 3](#F3){ref-type="fig"} shows the results obtained from DU145 cells loaded with medium BNF-Starch concentration after digestion with concentrated nitric acid for varying times at 70 °C. As shown in [Figure 3](#F3){ref-type="fig"}, a 1-h digestion was sufficient to yield constant values of measured iron, implying that liberation of the intracellular iron with longer digestion times of up to and over 16 h did not yield additional significant differences of measured iron concentrations.

Comparison to Riemer's method {#S15}
-----------------------------

We next compared results obtained from the ferene-s assay of nanoparticle iron quantification to results obtained using the method presented by Riemer *et al.* \[[@R34]\], one of the most common methods used for these measurements. Measured iron content obtained using Riemer's method is significantly lower than the iron concentrations measured by the ferene-s method for all formulations comprising core--shell particles ([Figure 4(A)](#F4){ref-type="fig"}). Interestingly, dextran matrix formulations -- Miltenyi beads and nanomag^®^-D-spio particles -- yielded similar measured iron values between the two methods. When comparing iron concentration measured from cells that internalised BNF-Starch nanoparticles, we find again the intracellular iron measurements obtained using Riemer's method are significantly lower than those obtained using ferene-s or ICP-MS ([Figure 4(B)](#F4){ref-type="fig"}). Between them, ICP-MS and ferene-s yielded consistent results.

Modified protocol to correct for path length for 96-well plate readers {#S16}
----------------------------------------------------------------------

Results of comparing iron concentration measurements obtained from 96-well plate reader are shown in [Supplementary Table S4](#SD1){ref-type="supplementary-material"} and [Figure 1(C)](#F1){ref-type="fig"}. The average slope of total net absorbance for Fe standards is about 1.7 absorbance units per μg of iron with 4.4% coefficient of variation. The total amount of iron in an unknown sample could be determined by dividing the total absorbance units of the unknown by this slope. The slope of Fe standard curves is highly reproducible and reliable when performed in this manner. [Supplementary Table S7](#SD1){ref-type="supplementary-material"} shows the results from five experiments performed on different days with the mean ± SD of 1.71 ± 0.06 (3.3% CV).

Discussion {#S17}
==========

Applications of iron oxide nanoparticles include many examples in biology and medicine. Characterization of their effects on biological processes, including toxicity, in cell culture model systems requires accurate determination of nanoparticle, that is iron ion concentration to evaluate concentration-dependent effects. For imaging and hyperthermia, accurate iron quantification in the cell or biological sample material is required to correctly interpret the translational implications of dose--response effects. Many methods are available to characterise iron concentrations, however the most reliable and accurate methods require expensive equipment and elaborate sample preparation protocols. Thus, accurate and reliable iron concentration measurements are inaccessible to researchers who lack the necessary infrastructure and equipment. In this report we described the development of a simple, rapid, low-cost and reliable method to quantify iron ion concentration in samples containing iron oxide nanoparticles. We have optimised the assay for use with various formulations of iron oxide nanoparticles as well as their intracellular concentration. Furthermore, the assay is validated by comparison with standard reference materials and ICP-MS.

Colorimetric methods utilising chromogenic compounds such as ferrozine or ferene to assay iron concentrations are among the most widely used and are commercially available. They are generally optimised for use in either clinical or environmental applications \[[@R26],[@R33],[@R36],[@R41]--[@R45]\]. A common feature of nearly all spectrophotometer-based methods of iron mass quantitation is an initial iron ion liberation ("digestion") process that separates individual iron ions from the biological or environmental sample matrices. A reducing agent is then used to convert the ferric (Fe^3+^) iron in the sample to ferrous, Fe^2+^, iron. The measured concentration of iron in the sample will be inaccurate and typically underestimated if any iron in the sample remains bound to the matrix material, or remains in the trivalent state (typically the result of vigorous digestion of sample with corrosive agents).

Spectrometric techniques, such as ICP-MS or ICP-AES, are typically sensitive and require no reduction of the iron ions after their liberation. On the other hand, sample preparation and instrument configuration can negate the high sensitivity by failing to resolve differences with sample components or other contaminants. Furthermore, equipment costs and infrastructure demands make acquisition and maintenance of ICP-MS equipment prohibitive thus limiting access for many research laboratories.

With the simplified method reported here, which requires reagents and a UV/Vis spectrophotometer, we describe the preparation of a working solution to which samples can be directly added; and, after thorough mixing the solution is incubated at room temperature overnight. The working solution comprises a 0.2 M acetate buffer at \~pH 4.3 and 0.2 M ascorbic acid acting as the reducing agent. Given adequate time this acidic solution is sufficient to liberate iron ions from the nanoparticles and the sample matrix. Complete liberation of iron ions depends upon the nanoparticle formulation, nanoparticle coating(s), and other sample details. It is worth noting that selection of nanoparticles for the present study was limited to a subset of commercially available nanoparticle constructs comprising iron oxide and dextran or starch coatings or matrices for development of methodology and validation. Such constructs have demonstrated widespread utility in biomedical research and clinical applications. All possible and available nanoparticles having similar composition; however, were not tested but methods described can be used. Iron oxide nanoparticles comprising inorganic coatings or matrices, for example SiO~2~, Au, Zn, etc., were not tested in the present study. Such particle constructs may require modified digestion reagents and time. In such cases; however, the methods described herein for measurement of liberated iron ion concentrations following appropriate digestion may still be used.

For the described samples containing cell matrices, the time needed to achieve complete iron ion liberation also depends upon location of nanoparticles outside or within intracellular compartments or organelles of the cell. Absorbance readings measured from the Miltenyi microbeads became constant within \~3 h after addition to the working solution. This was approximately half the time needed for BNF-Starch particles ([Figure 2(A)](#F2){ref-type="fig"}). We may consider that such differences of digestion time may be due to the aggregated (BNF) vs. dispersed iron oxide crystallite (Miltenyi beads) configurations of the nanoparticle constructs. Further investigation, however is needed to determine the cause of the difference in digestion times. When associated with cellular material, however the BNF-Starch particles required \>12 h to achieve constant values ([Figure 2(B)](#F2){ref-type="fig"}). FeCl~3~ used as standard reached saturation in fewer than 30 min ([Supplementary Figure S1](#SD1){ref-type="supplementary-material"}) suggesting that reduction of Fe^3+^ to Fe^2+^ by ascorbic acid is not the limiting factor. Instead, liberation of iron ions from within the nanoparticle or sample matrix appears to vary significantly. For faster processing, the samples can be digested with concentrated nitric acid prior to addition to the working solution. As shown in [Figure 3](#F3){ref-type="fig"}, a 1-h digestion with acid at \~70 °C was sufficient for complete release of iron from intracellular BNF-Starch nanoparticles. When using nitric acid to effect sample digestions, it is important to neutralise the digested sample solution with base, for example NaOH, in order to maintain pH = 3--6 before adding to the working solution \[[@R32]\].

The method described by Riemer *et al.* \[[@R34]\] utilises a potassium permanganate and HCl mixture to effect sample digestion (2 h incubation at 60 °C). Comparison of results obtained by the ferene-s and Riemer methods in [Figure 4(A) and (B)](#F4){ref-type="fig"} demonstrates that the latter method may significantly underestimate the iron concentration depending upon the nanoparticle construct under study. Thus, caution should be exercised when interpreting results obtained by Riemer's method for iron oxide nanoparticles. When compared against ICP-MS (see [Figure 4(B)](#F4){ref-type="fig"}), the consistency between the ferene-s and ICP-MS values implies that the lower iron concentration obtained using Riemer's method may be due to incomplete iron ion liberation. With this method, longer digestion times or digestion by a concentrated acid may be necessary to avoid underestimating iron content in the sample. Further, absent a validation with an orthogonal and sensitive methodology, that is ICP-MS, it is recommended to evaluate concentration measurements using Riemer's method following an analysis of results obtained from a time- and concentration-dependent study matrix to identify the optimal digestion and sample preparation procedure(s). On the other hand, the ferene-s procedure described above demonstrates consistent iron ion concentration measurements as validated by comparison with ICP-MS for several different iron oxide nanoparticles and cell-internalised BNF-Starch nanoparticles (see [Table 1](#T1){ref-type="table"}).

To develop our assay, the chromogenic compound ferene-s was chosen because its higher molar absorptivity compared to ferrozine ([Figure 1](#F1){ref-type="fig"}, [Supplementary Table S1](#SD1){ref-type="supplementary-material"}). The molar absorptivity was calculated from the Beer--Lambert law: *A* = ε*lc;* where *A* is the absorbance, ε is the molar absorptivity, *l* is the path length and *c* is the concentration of the sample. When using a standard UV/Vis cuvette (usually with a fixed path length of 1 cm) the light passes through the sample horizontally and is therefore independent of the sample volume. The ferene-s assay protocol reported here uses a 96-well plate format for absorbance readings to facilitate high throughput processing. It is important to note however that microplate readers use a vertical light path and the distance for light to travel through the sample depends on the sample volume. To compare the absorbance readings between standard 1-ml UV/Vis cuvettes and 96-well plates we performed four independent experiments with iron standards ranging in concentration from 0 to 4.0 μg Fe/ml. In each experiment the same sample was used for both readings. The results are shown in [Supplementary Tables S3 and S4](#SD1){ref-type="supplementary-material"}. Absorbance readings were about 20% lower when measured with 96-well plates. This is expected because the approximate height of the 300 μl solution in each well is \~0.88 cm. When adjusted to a height of 1 cm the readings remained about 8--9% lower than when measured with 1-ml cuvettes. The plate reader used for our absorbance measurements incorporates a path-check option in its software which automatically adjusts the absorbance readings to match the readings from a 1-ml cuvette. When using this option the absorbance readings from the 96-well plates were similar to those obtained using a 1-ml cuvette (compare [Supplementary Tables S3 and S5](#SD1){ref-type="supplementary-material"}).

If available, the use of this option in the UV/Vis spectrophotometer enables more consistent results. This option however may be unavailable with some models of plate readers therefore a modified method is needed to obtain consistency among experimental values. We described a procedure to account for variations of path length that employs use of the slope of absorbance calibration curve obtained from the reference standard solutions, to yield reproducible and reliable measurements.

Conclusion {#S18}
==========

We present a detailed protocol for iron concentration determination using a ferene-s assay. The results were obtained from several iron oxide nanoparticle constructs used for biomedical applications. We also present results of iron concentration measurements obtained from cell culture comparing three methods to demonstrate that, depending upon method chosen, sample digestion may yield unreliable results. The ferene-s method developed was validated against ICP-MS demonstrating reproducible measurements of Fe concentrations to \~2 × 10^−6^ M (1 × 10^−7^ g/ml sample). The reliability and convenience of the ferene-s protocol demonstrated can facilitate rapid and accurate iron oxide nanoparticle concentration measurements for a range of biological and toxicological experiments utilising cell culture models.

Supplementary Material {#S19}
======================
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![Comparison of the spectra of the iron standards (0--2 μg Fe^+3^) in working solution. Ferene-s (A), ferrozine (B), and the corresponding standard curves (0.1--4 μg Fe^+3^) measured at the peak absorbance for each compound (560 nm for ferrozine and 595 nm for ferene-s), (C).](nihms951650f1){#F1}

![Time course of absorbance at 595 nm for ferene-s assay in working solution. Iron oxide nanoparticles with various formulations (A) and intracellular BNF-Starch iron oxide nanoparticles (B), DU145 cells with low, medium and high Fe content). Absorbance readings are adjusted to reflect equivalent number of cells.](nihms951650f2){#F2}

![Digestion with concentrated nitric acid. Intracellular BNF-Starch iron oxide nanoparticles digested at various times at 70 °C prior to addition to the working solution.](nihms951650f3){#F3}

![Comparison with Riemer's method. Iron oxide nanoparticles with various formulations (A) and intracellular BNF-Starch iron oxide nanoparticles (B). Identical samples for each formulation of nanoparticles or DU145 cells loaded with BNF-Starch were prepared in duplicates.](nihms951650f4){#F4}

###### 

Iron concentrations obtained from various iron oxide nanoparticles.

  Nanoparticles                    ICP-MS[a](#TFN1){ref-type="table-fn"} (μg Fe)   Ferene-s[a](#TFN1){ref-type="table-fn"} (μg Fe)
  -------------------------------- ----------------------------------------------- -------------------------------------------------
  nanomag^®^-D-spio                  4.7 ± 0.3                                       5.0 ± 0.3
  BNF-Starch                         5.7 ± 0.6                                       5.8 ± 0.4
  Miltenyi anti-ErbB2 microbeads     4.9 ± 0.4                                       4.8 ± 0.2
  Miltenyi basic microbeads          5.1 ± 0.9                                       4.6 ± 0.3
  Intracellular BNF-Starch         45.5 ± 14.6 (n = 7)                             44.3 ± 5.0 (*n* = 20)

Data are reported as mean ± SD, and *n* = 2 unless otherwise noted.
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